Successful IPO of MEDESIS PHARMA, a biotechnology pharmaceutical company, on Euronext
COVID-19 TREATMENTS Using its drug delivery technology, MEDESIS PHARMA has implemented
Alzheimer’s disease is the most frequent cause of dementia and one of the most
The objective of the radioprotection program is to develop a radiomitigation drug,
Directly linked to 137Cs are numerous diseases not only limited to the increased
After a civil or military accident, involving nuclear material, dispersed radioactive
